Alcon Inc. (LON:0A0D)

London flag London · Delayed Price · Currency is GBP · Price in CHF
71.58
-0.19 (-0.26%)
Jul 22, 2022, 8:20 AM BST
-6.51%
Market Cap29.34B
Revenue (ttm)7.58B
Net Income (ttm)778.91M
Shares Outn/a
EPS (ttm)1.56
PE Ratio37.66
Forward PE24.03
Dividend0.25 (0.35%)
Ex-Dividend DateMay 13, 2025
Volume110
Average Volume349,987
Open72.10
Previous Close71.77
Day's Range71.58 - 72.10
52-Week Range57.70 - 86.98
Beta0.69
RSI52.99
Earnings DateFeb 26, 2026

About Alcon

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. It operates through two segments, Surgical and Vision Care. The company offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. Its cataract products include Centurion vision system, LenSx laser system, Verion reference unit and Verion digital marker, ... [Read more]

Sector Healthcare
Founded 1945
Employees 25,599
Stock Exchange London Stock Exchange
Ticker Symbol 0A0D
Full Company Profile

Financial Performance

In 2024, Alcon's revenue was $9.91 billion, an increase of 4.82% compared to the previous year's $9.46 billion. Earnings were $1.02 billion, an increase of 4.52%.

Financial numbers in USD Financial Statements

News

There is no news available yet.